Morning-after pill: how a free pharmacy scheme reached hundreds of thousands of women
Health officials in England say a scheme quietly launched last October has reached far more women than initially expected. Under the NHS-backed plan, hundreds of pharmacies across the country can now dispense the morning-after pill free of charge. Previously, women either needed a GP prescription or had to pay up to £25 over the counter.
Officials say hundreds of thousands of women have used the service since it began. The figure has drawn attention to just how limited access to emergency contraception had become, particularly in lower-income areas. Nurses working in women's health say they had regularly seen patients decide against taking the pill purely because of the cost.
The morning-after pill is used to prevent pregnancy after unprotected sex or contraceptive failure, and its effectiveness depends heavily on how quickly it is taken. It is generally recommended within 72 hours, though some formulations remain effective for up to five days. Experts stress that in this race against time, financial barriers can be decisive.
Supporters of the scheme argue that free access benefits not just individual women but the wider public health system. Preventing unplanned pregnancies can, over time, reduce demand on abortion services and ease pressure on women's health budgets. Some researchers point to similar free-access models abroad that have coincided with falling termination rates.
Critics have raised questions about how the scheme is funded and whether pharmacies can absorb the added workload. Some pharmacists say the time available for consultation is limited, and warn that quality of care must not be sacrificed for speed. Department of Health officials say early evaluation results have been positive and that an expansion is being planned.
A significant share of the women using the service are young adults and students — groups who may not be registered with a regular GP or who struggle to get urgent appointments. Because pharmacies often open on weekends and evenings, they offer a far more flexible access point than the traditional health system.
Experts are careful to note that the morning-after pill is not intended as a routine contraceptive method — it is designed strictly for emergencies. Even so, pharmacists say the interaction gives them a chance to discuss longer-term contraceptive options with women who might otherwise never raise the subject.
Similar free-access models were introduced earlier in Scotland and Wales, and England's move is seen as part of a broader push to bring women's health services into closer alignment across the UK. Women's health organisations are now pushing for the same principle to be extended to other essential services, such as emergency contraceptive implants.
A fuller evaluation of the scheme is expected at the end of its first year. Officials say the data should clarify both the scale of the access gap it has closed and any cost savings to the health service, shaping future policy decisions.
For now, the early results suggest that removing even a seemingly small barrier — cost — can have an outsized effect on women's healthcare decisions.
Read next
Can a daily fiber supplement ease knee arthritis pain?
In a six-week clinical trial, a prebiotic fiber supplement reduced knee osteoarthritis pain while also improving grip strength and pain sensitivity. The results point to a fascinating gut-muscle-pain connection that researchers are only beginning to understand. Scientists suggest a simple daily supplement may prove easier for patients to stick with than digital physiotherapy programmes.
Why losing the wrong kind of fat can trigger diabetes
New research finds that damaged fat cells can become inflamed, lose their ability to store lipids, and eventually vanish, disrupting the body's metabolism in the process. The findings show that diabetes can result not only from excess fat, but also from losing the healthy fat tissue the body actually needs. It's a finding that challenges the conventional story of how the disease develops.
What is ex-vivo lung perfusion, and how it's saving more donor organs
England's health quality watchdog, NICE, has backed wider use of a machine that keeps donated lungs alive outside the body, a technology that could save up to four in five donor lungs currently going to waste. The UK has one of the poorest lung transplant rates in the world, with 170 patients — including six children — currently waiting for new lungs.
HIV funding: why an 18% drop in global financing has experts fearing a resurgence
A new UNAIDS report finds that global funding to fight HIV fell 18% last year, a drop the agency calls a "profound shock" to the international response. Experts warn that cuts to treatment and prevention programmes could drive a rise in new infections, particularly in lower-income countries. The report highlights the risk of reversing decades of hard-won progress against the epidemic.
UK aid worker evacuated to London hospital for Ebola monitoring after DR Congo exposure
A British humanitarian worker has been evacuated to a London hospital for monitoring after potential exposure to Ebola while working in the Democratic Republic of Congo. The worker is under isolation precautions and has not been confirmed to have symptoms. The case illustrates how the region's ongoing outbreak is prompting international health systems into precautionary action.